Canaccord Adams Reiterates a 'Hold' on Myriad Genetics (MYGN); Lowers Estimates & Price Target
Tweet Send to a Friend
Canaccord Adams reiterates a 'Hold' on Myriad Genetics (Nasdaq: MYGN). Price target lowers price target by $1 to $38.
Canaccord ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
